Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00108_DB00262_nanopub.RAMUjsAAnKEg6vfRmbE0d_o7N0JEpTVPIF6PdS4zYDzxQ#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00108_DB00262 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00108_DB00262 label "DDI between Natalizumab and Carmustine - Immunosuppressants such as carmustine may enhance the adverse/toxic effect of natalizumab. Specifically, the risk of concurrent infection may be increased. Patients receiving natalizumab should not use concurrent immunosuppressants. [drugbank_resource:DB00108_DB00262]" assertion.
- drugbank_resource:DB00108_DB00262 identifier "drugbank_resource:DB00108_DB00262" assertion.
- drugbank_resource:DB00108_DB00262 title "DDI between Natalizumab and Carmustine - Immunosuppressants such as carmustine may enhance the adverse/toxic effect of natalizumab. Specifically, the risk of concurrent infection may be increased. Patients receiving natalizumab should not use concurrent immunosuppressants." assertion.
- drugbank:DB00262 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00108_DB00262 assertion.
- drugbank:DB00108 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00108_DB00262 assertion.